Skip to main content
SpringerLink
Log in
Book cover

Advances in Radiation Oncology in Lung Cancer pp 173–186Cite as

PET and PET/CT in Treatment Planning

  • Chapter
  • First Online:

  • 1754 Accesses

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

Abstract

Positron emission tomography (PET) is a major advance in lung cancer imaging and is having an increasing impact on the management of patients with non-small cell lung cancer who are candidates for potentially-curative treatment with radiotherapy. PET imaging, using 18F-flurodeoxyglucose as the tracer, and more recently in the form of FDG-PET/CT is now the most important single imaging modality for staging, patient selection and radiotherapy planning in NSCLC. If scans are acquired under appropriate conditions and the patient is positioned for radiotherapy, a single scan can be used for all of these purposes. In this chapter the role of PET and PET/CT in staging, patient selection and radiotherapy planning are discussed. Additionally, the use of FDG-PET for response assessment is described and finally the potential value of PET tracers other than FDG is considered.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Ball D, Smith J, Wirth A, Mac Manus M (2002) Failure of T stage to predict survival in patients with non-small-cell lung cancer treated by radiotherapy with or without concomitant chemotherapy. Int J Radiat Oncol Biol Phys 54:1007–1013

    Article  PubMed  CAS  Google Scholar 

  • Bayne M et al (2010) Reproducibility of “intelligent” contouring of gross tumor volume in non-small-cell lung cancer on PET/CT images using a standardized visual method. Int J Radiat Oncol Biol Phys 77:1151–7

    Article  PubMed  Google Scholar 

  • Biehl KJ et al (2006) 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate? J Nucl Med 47:1808–1812

    PubMed  Google Scholar 

  • Binns DS et al (2011) Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging 38:642–650

    Article  PubMed  CAS  Google Scholar 

  • Blum R et al (2004) Impact of positron emission tomography on the management of patients with small-cell lung cancer: preliminary experience. Am J Clin Oncol 27:164–171

    Article  PubMed  Google Scholar 

  • Bowden P et al (2002) Measurement of lung tumor volumes using three-dimensional computer planning software. Int J Radiat Oncol Biol Phys 53:566–573

    Article  PubMed  Google Scholar 

  • Bradley JD et al (2004) Positron emission tomography in limited-stage small-cell lung cancer: a prospective study. J Clin Oncol 22:3248–3254

    Article  PubMed  Google Scholar 

  • Buck AK et al (2010) Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches. J Nucl Med Technol 38:6–17

    Article  PubMed  Google Scholar 

  • Caldwell CB et al (2001) Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion. Int J Radiat Oncol Biol Phys 51:923–931

    Article  PubMed  CAS  Google Scholar 

  • Dahele M et al (2008) Developing a methodology for three-dimensional correlation of PET-CT images and whole-mount histopathology in non-small-cell lung cancer. Curr Oncol 15:62–69

    Article  PubMed  CAS  Google Scholar 

  • Deniaud-Alexandre E et al (2005) Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 63:1432–1441

    Article  PubMed  Google Scholar 

  • De Ruysscher D et al (2005) Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: a planning study. Radiother Oncol 77:5–10

    Article  PubMed  Google Scholar 

  • Dunagan D et al (2001) Staging by positron emission tomography predicts survival in patients with non-small cell lung cancer. Chest 119:333–339

    Article  PubMed  CAS  Google Scholar 

  • Eschmann SM et al (2007) Impact of staging with 18F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivors. Eur J Nucl Med Mol Imaging 34:54–59

    Article  PubMed  CAS  Google Scholar 

  • Everitt S et al (2009) Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 75:1098–1104

    Article  PubMed  Google Scholar 

  • Everitt S et al (2010) High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer. Cancer 116:5030–5037

    Article  PubMed  Google Scholar 

  • Gould MK et al (2003) Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med 139:879–892

    Article  PubMed  Google Scholar 

  • Gregoire V, Haustermans K, Geets X, Roels S, Lonneux M (2007) PET-based treatment planning in radiotherapy: a new standard? J Nucl Med 48(Suppl 1):68S–77S

    PubMed  CAS  Google Scholar 

  • Hicks RJ (2009) Role of 18F-FDG PET in assessment of response in non-small cell lung cancer. J Nucl Med 50(Suppl 1):31S–42S

    Article  PubMed  CAS  Google Scholar 

  • Hicks RJ, Mac Manus MP (2003) 18F-FDG PET in candidates for radiation therapy: is it important and how do we validate its impact? J Nucl Med 44:30–32

    PubMed  Google Scholar 

  • Hicks RJ et al (2001) (18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer. J Nucl Med 42:1596–1604

    PubMed  CAS  Google Scholar 

  • Higashi K et al (2000) FDG PET measurement of the proliferative potential of non-small cell lung cancer. J Nucl Med 41:85–92

    PubMed  CAS  Google Scholar 

  • Hong R, Halama J, Bova D, Sethi A, Emami B (2007) Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning. Int J Radiat Oncol Biol Phys 67:720–726

    Article  PubMed  Google Scholar 

  • Jaffe CC (2006) Measures of response: RECIST, WHO, and new alternatives. J Clin Oncol 24:3245–3251

    Article  PubMed  Google Scholar 

  • Koizumi M et al (2011) Uptake decrease of proliferative PET tracer FLT in bone marrow after carbon ion therapy in lung cancer. Mol Imaging Biol 13:577–582

    Article  PubMed  Google Scholar 

  • Kolodziejczyk M et al (2011) Impact of [(18)F]Fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys 80(4):1008–1114

    Article  PubMed  Google Scholar 

  • Lever AM, Henderson D, Ellis DA, Corris PA, Gilmartin JJ (1984) Radiation fibrosis mimicking local recurrence in small cell carcinoma of the bronchus. Br J Radiol 57:178–180

    Article  PubMed  CAS  Google Scholar 

  • Mac Manus MP et al (2010) Association between pulmonary uptake of fluorodeoxyglucose detected by positron emission tomography scanning after radiation therapy for non-small-cell lung cancer and radiation pneumonitis. Int J Radiat Oncol Biol Phys 80:1365–1371

    Article  PubMed  Google Scholar 

  • Mac Manus MP et al (2001) F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment. Cancer 92:886–895

    Article  PubMed  CAS  Google Scholar 

  • Mac Manus MP et al (2002) Early mortality after radical radiotherapy for non-small-cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral center. Int J Radiat Oncol Biol Phys 52:351–361

    Article  PubMed  Google Scholar 

  • Mac Manus MP et al (2003) Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer. J Clin Oncol 21:1285–1292

    Article  PubMed  Google Scholar 

  • MacManus MR et al (2003) FDG-PET-detected extracranial metastasis in patients with non-small cell lung cancer undergoing staging for surgery or radical radiotherapy—survival correlates with metastatic disease burden. Acta Oncol 42:48–54

    Article  PubMed  Google Scholar 

  • MacManus M et al (2009) Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006–2007. Radiother Oncol 91:85–94

    Article  PubMed  Google Scholar 

  • Mah K et al (2002) The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study. Int J Radiat Oncol Biol Phys 52:339–350

    Article  PubMed  Google Scholar 

  • Mileshkin L et al (2011) Changes in 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine position emission tomography imaging in patients with non-small cell lung cancer treated with erlotinib. Clin Cancer Res 17:3304–3315

    Article  PubMed  CAS  Google Scholar 

  • Munley MT et al (1999) Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects. Lung Cancer 23:105–114

    Article  PubMed  CAS  Google Scholar 

  • Nehmeh SA et al (2002) Effect of respiratory gating on quantifying PET images of lung cancer. J Nucl Med 43:876–881

    PubMed  Google Scholar 

  • Nestle U et al (2006) Target volume definition for (18)F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging 33:263–269

    Article  Google Scholar 

  • Nestle U et al (1999) 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. Int J Radiat Oncol Biol Phys 44:593–597

    Article  PubMed  CAS  Google Scholar 

  • Nestle U et al (2005) Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. J Nucl Med 46:1342–1348

    PubMed  Google Scholar 

  • Pauleit D et al (2005) PET with O-(2–18F-Fluoroethyl)-l-Tyrosine in peripheral tumors: first clinical results. J Nucl Med 46:411–416

    PubMed  CAS  Google Scholar 

  • Pommier P et al (2010) Impact of (18)F-FDG PET on treatment strategy and 3D radiotherapy planning in non-small cell lung cancer: A prospective multicenter study. AJR Am J Roentgenol 195:350–355

    Article  PubMed  Google Scholar 

  • Reischl G et al (2007) Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA–first small animal PET results. J Pharm Pharm Sci 10:203–211

    PubMed  CAS  Google Scholar 

  • Sasaki M et al (2001) Comparison of MET-PET and FDG-PET for differentiation between benign lesions and malignant tumors of the lung. Ann Nucl Med 15:425–431

    Article  PubMed  CAS  Google Scholar 

  • Stroobants S, Verschakelen J, Vansteenkiste J (2003) Value of FDG-PET in the management of non-small cell lung cancer. Eur J Radiol 45:49–59

    Article  PubMed  Google Scholar 

  • Toloza EM, Harpole L, Detterbeck F, McCrory DC (2003) Invasive staging of non-small cell lung cancer: a review of the current evidence. Chest 123:157S–166S

    Article  PubMed  Google Scholar 

  • Townsend DW, Beyer T (2002) A combined PET/CT scanner: the path to true image fusion. Br J Radiol 75(Spec No):S24–S30

    PubMed  Google Scholar 

  • van Baardwijk A et al (2007) PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes. Int J Radiat Oncol Biol Phys 68:771–778

    Article  PubMed  Google Scholar 

  • van de Steene J et al (2002) Definition of gross tumor volume in lung cancer: inter-observer variability. Radiother Oncol 62:37–49

    Article  PubMed  Google Scholar 

  • van Der Wel A et al (2005) Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study. Int J Radiat Oncol Biol Phys 61:649–655

    Article  Google Scholar 

  • van Loon J et al (2008) 18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study. Radiother Oncol 87:49–54

    Article  PubMed  Google Scholar 

  • Vanuytsel LJ et al (2000) The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol 55:317–324

    Article  PubMed  CAS  Google Scholar 

  • Wahl RL, Jacene H, Kasamon Y, Lodge MA (2009) From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors. J Nucl Med 50(suppl 1):122S–150S

    Article  PubMed  CAS  Google Scholar 

  • Wurm RE et al (2006) Image guided respiratory gated hypofractionated stereotactic body radiation therapy (H-SBRT) for liver and lung tumors: initial experience. Acta Oncol 45:881–889

    Article  PubMed  CAS  Google Scholar 

  • Yaremko B et al (2005) Thresholding in PET images of static and moving targets. Phys Med Biol 50:5969–5982

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Peter MacCallum Cancer Centre, St Andrew’s Place, East Melbourne, VIC, 3002, Australia

    Michael P. Mac Manus

  2. Centre for Molecular Imaging, Peter MacCallum Cancer Centre, St Andrew’s Place, East Melbourne, VIC, 3002, Australia

    Rodney J. Hicks

Authors
  1. Michael P. Mac Manus
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rodney J. Hicks
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael P. Mac Manus .

Editor information

Editors and Affiliations

  1. Institute of Lung Diseases, Institutski put 4, Sremska Kamenica, 21204, Serbia

    Branislav Jeremic

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Mac Manus, M.P., Hicks, R.J. (2011). PET and PET/CT in Treatment Planning. In: Jeremic, B. (eds) Advances in Radiation Oncology in Lung Cancer. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2011_300

Download citation

  • DOI: https://doi.org/10.1007/174_2011_300

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-19924-0

  • Online ISBN: 978-3-642-19925-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation